Skip to main content
Equibles
ARDT logo

ARDT · Ardent Health, Inc. · Metrics

Track ARDT — free

Use ARDT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ARDT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$12.27 -0.09 (-0.73%)
Russell 2000 member Rebalance outlook locked
Market Cap
$1.73B
Shares
141.05M
Volume · Oct 23 358.71K Avg daily vol (3M) 453.72K

ARDT metrics

74 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$12.27
Market cap
$1.73B

Price action

20 metrics
Price change (1W)
+1.3%
Price change (30D)
+12.9%
Price change (3M)
+18.6%
Price change (6M)
+27.7%
Price change (YTD)
+40.0%
Price change (1Y)
-16.7%
Trailing year
Price change (5Y)
—
52-week high
$15.21
52-week low
$7.83
Change from 52-week high
-18.7%
Change from 52-week low
+57.9%
Annualized volatility
54.0%
Annualized volatility (3M)
33.5%
Beta
1.1
RSI (14D)
69.0
Price vs SMA 50
+12.3%
Price vs SMA 200
+25.0%
Avg volume (3M)
454,244
Relative volume
0.7
Average dollar volume
$5.02M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
141.05M

Valuation

12 metrics
P / E (TTM)
22.5
Trailing earnings · reciprocal yield 4.4%
PEG ratio
—
EV / revenue
0.3×
reciprocal yield 304.3%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.3×
reciprocal yield 370.8%
P / book
1.3
reciprocal yield 78.2%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
3.4
reciprocal yield 29.8%
Earnings yield
4.5%

Historical valuation

8 metrics
P / E historical average (3Y)
10.1×
reciprocal yield 9.9%
P / E historical average (5Y)
10.1×
reciprocal yield 9.9%
EV / revenue historical average (3Y)
0.3×
reciprocal yield 310.9%
EV / revenue historical average (5Y)
0.3×
reciprocal yield 310.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-05
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
1.2%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
$78.23M
Trailing 12 months
Diluted EPS (TTM)
$0.55
FCF margin
—
Effective tax rate
18.9%

Per share

11 metrics
Revenue per diluted share (TTM)
$45.08
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$0.55
Operating cash flow per diluted share (TTM)
$3.61
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$9.01

Growth

11 metrics
Revenue growth YoY
-1.4%
Year over year
Net income growth YoY
-76.8%
Revenue (TTM)
$6.41B
Trailing 12 months
EPS growth YoY
-76.9%
Shares change YoY
+1.1%
Year over year · more shares
Revenue CAGR (3Y)
+7.2%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
-13.8%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
5.8%
Return on assets
1.5%
Debt / equity
0.8
Current ratio
2.1
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
2.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$377.31M
Latest balance sheet
Cash & equivalents
$724.48M
Total assets
$5.28B
Total debt
$1.10B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$514.32M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
138
13F filer change QoQ
+1
Institutional ownership
76.9%
Conviction holders (share of 13F filers)
1.4%
Crowding (high-turnover and private-fund holders)
6.5%
Private-fund adviser ownership
6.1%
Active holders' share change QoQ
+1.3%
Holder tenure
7.2
Price vs estimated holder cost
-40.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
2.8%

Short interest

3 metrics
Short interest
3.3%
Latest settlement · 10.7 days to cover
Days to cover
10.7d
Short-squeeze score
66 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1756655 CUSIP 03980N107 13F (30d) 17 filings 17 filers Visit website Investor relations